Keyword: PhRMA

The Trump administration’s plan to end legal protections for drug rebates would boost Part D premiums and federal spending, according to CBO. 

Executives at five pharmacy benefit managers (PBMs) are confirmed for an April hearing on drug prices, plus more insurance headlines.

Anthem Blue Cross Blue Shield Indiana launched a partnership to provide Medicaid beneficiaries free legal assistance, plus more payer news.

HHS Secretary Alex Azar is challenging Congress to take up the administration’s plan to end safe harbor protections for drug rebates. 

CareFirst is donating $1.5 million to charities that assist federal workers affected by the government shutdown, plus more insurance headlines.

HHS’ drug pricing plans are meant to signal to the healthcare industry—and voters—that it's serious on this issue, experts say. 

CMS wants drug companies to put their list prices in television ads, but whether that policy is something it can enforce remains a major question. 

The Trump administration is planning to force drug companies to include the list price of their products in direct-to-consumer advertising.

The drug industry continued its campaign to spread the blame for high prescription drug prices with its latest commissioned analysis.

The Trump administration is considering a proposal to overhaul safe harbor protections for pharmaceutical company rebates.